Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Brain Res ; 347(2): 268-73, 1985 Nov 18.
Artigo em Inglês | MEDLINE | ID: mdl-2998554

RESUMO

Pharmacological protection of central neural function against damage by hypoxia and reoxygenation was studied electrophysiologically and biochemically in hippocampal brain slices. Hypoxia causes a loss of both orthodromically and antidromically evoked potentials in CA1 pyramidal cell neurons. Damage due to hypoxia lasting more than 10 min cannot be restored by reoxygenation. Following pretreatment with methylprednisolone (10(-5) M), indomethacin (10(-5) M) or allopurinol (10(-5) M), reoxygenation after 10 min of hypoxia resulted in complete recovery of the evoked activity. Na+,K+-ATPase activity was not reduced by 10 min of hypoxia, but was reduced by 50% during the first 10 min of subsequent reoxygenation. Allopurinol (10(-5) M) protected against loss of this enzyme activity. The protective action by these drugs of both electrophysiological and biochemical aspects of neural function is consistent with the hypothesis that secondary ischemic damage is caused by the formation of oxygen-derived free radicals during reperfusion.


Assuntos
Hipocampo/fisiopatologia , Hipóxia Encefálica/metabolismo , Metilprednisolona/farmacologia , Consumo de Oxigênio/efeitos dos fármacos , Alopurinol/farmacologia , Animais , Química Encefálica/efeitos dos fármacos , Sobrevivência Celular , Potenciais Evocados/efeitos dos fármacos , Hipóxia Encefálica/patologia , Indometacina/farmacologia , Masculino , Ratos , ATPase Trocadora de Sódio-Potássio/metabolismo , Fatores de Tempo
2.
Otolaryngol Head Neck Surg ; 106(2): 181-8, 1992 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-1738551

RESUMO

Immunologic defense factors in the human olfactory mucosa were localized immunohistochemically. Olfactory epithelium was identified with an antiserum to olfactory marker protein, specific for olfactory receptor neurons. Constituents of the secretory immune system, including IgA, IgM, secretory component, and J chain, were localized in the acinar and duct cells of Bowman's glands and in the mucociliary complex. In addition, B lymphocytes in the lamina propria near Bowman's glands displayed immunoreactivity for IgA, IgM, and J chain. Immunostaining also localized other humoral factors. Immunoreactivity for IgG was present throughout the stroma and in B lymphocytes in the lamina propria. Antibody to IgD stained numerous B lymphocytes clustered below the basement membrane. Antibody to IgE stained similarly distributed cells; toluidine blue staining demonstrated that many were mast cells. In addition, antibodies to IgD and IgE stained occasional intraepithelial B lymphocytes or mast cells. Two antimicrobial proteins, lactoferrin and lysozyme, were localized in Bowman's glands and the mucociliary complex. Thus, the human olfactory mucosa, which provides a direct neural route for pathogens to the brain, is a site for synthesis and secretion of immune and other defense factors.


Assuntos
Imunoglobulinas/análise , Mucosa Olfatória/imunologia , Adolescente , Adulto , Idoso , Linfócitos B/imunologia , Epitélio/imunologia , Osso Etmoide/imunologia , Feminino , Humanos , Imunoglobulina E/imunologia , Imunoglobulina G/imunologia , Cadeias J de Imunoglobulina/análise , Imuno-Histoquímica , Lactente , Masculino , Muramidase/análise , Septo Nasal/imunologia , Mucosa Olfatória/citologia , Componente Secretório/análise
3.
Am J Otol ; 12(6): 446-9, 1991 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1805636

RESUMO

Facial nerve monitoring during otologic and neurotologic procedures has been previously described, and its use is becoming routine. Although these procedures are done under general anesthesia, lidocaine is often used as a vehicle for epinephrine to aid hemostasis during the procedure. The routine use of lidocaine in these preparations presents the theoretical and sometimes real problem of anesthetizing the facial nerve at the start of the procedure, thereby invalidating subsequent attempts at monitoring and stimulation. We present the data from our experience with 74 patients using an epinephrine solution 1:100,000 for infiltration without any local anesthetic. We have found this procedure to be effective in maintaining hemostasis, quite safe and well tolerated, and without adverse effects on the desired monitoring of the facial nerve.


Assuntos
Epinefrina/uso terapêutico , Nervo Facial/fisiologia , Hemostasia Cirúrgica/métodos , Monitorização Intraoperatória/métodos , Pressão Sanguínea/efeitos dos fármacos , Epinefrina/farmacologia , Traumatismos do Nervo Facial , Frequência Cardíaca/efeitos dos fármacos , Humanos , Complicações Intraoperatórias/prevenção & controle , Estudos Prospectivos , Soluções
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA